Search

Your search keyword '"Acinetobacter immunology"' showing total 101 results

Search Constraints

Start Over You searched for: Descriptor "Acinetobacter immunology" Remove constraint Descriptor: "Acinetobacter immunology"
101 results on '"Acinetobacter immunology"'

Search Results

1. CCL28 modulates neutrophil responses during infection with mucosal pathogens.

2. Clinical Isolates of Acinetobacter spp. Are Highly Serum Resistant Despite Efficient Recognition by the Complement System.

3. Gut Bacteria Induce Granzyme B Expression in Human Colonic ILC3s In Vitro in an IL-15-Dependent Manner.

4. The skin microbiota as a link between rosacea and its systemic comorbidities.

5. Topical ozone therapy restores microbiome diversity in atopic dermatitis.

6. Inception of early-life allergen-induced airway hyperresponsiveness is reliant on IL-13 + CD4 + T cells.

7. Perinatal Bacterial Exposure Contributes to IL-13 Aeroallergen Response.

8. Human neutrophils phagocytose and kill Acinetobacter baumannii and A. pittii.

9. Gestational diabetes is associated with changes in placental microbiota and microbiome.

10. Bacterial superglue enables easy development of efficient virus-like particle based vaccines.

11. Acinetobacter nosocomialis secretes outer membrane vesicles that induce epithelial cell death and host inflammatory responses.

12. Fundamental immunological problems associated with "transmissible spongiform encephalopathies".

13. [Intestine microbiota and allergic diseases].

14. Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses.

15. A DNA break inducer activates the anticodon nuclease RloC and the adaptive immunity in Acinetobacter baylyi ADP1.

16. [Destabilization of homeostasis of organism of burn patients as a marker of sepsis development, its complications and outcome].

17. The role of Acinetobacter in the pathogenesis of multiple sclerosis examined by using Popper sequences.

18. Environmental biodiversity, human microbiota, and allergy are interrelated.

19. Epigenetic regulation in murine offspring as a novel mechanism for transmaternal asthma protection induced by microbes.

20. Allergic diseases, gene-environment interactions.

21. The allergy-protective properties of Acinetobacter lwoffii F78 are imparted by its lipopolysaccharide.

22. Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78.

24. Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties.

25. Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanism of ineffective host defense.

26. Bovine spongiform encephalopathy, multiple sclerosis, and creutzfeldt-jakob disease are probably autoimmune diseases evoked by Acinetobacter bacteria.

27. Acinetobacter immune responses in multiple sclerosis: etiopathogenetic role and its possible use as a diagnostic marker.

28. No evidence for production of intrathecal immunoglobulin G against Acinetobacter or Pseudomonas in multiple sclerosis.

29. [Spread of bacteria of the genus Acinetobacter in the hydrobios of the Bay of Peter the Great, the Sea of Japan].

30. Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis.

31. Antibodies to Acinetobacter bacteria and bovine brain peptides, measured in bovine spongiform encephalopathy (BSE) in an attempt to develop an ante-mortem test.

32. Identification of Acinetobacter isolates from species belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with monoclonal antibodies specific for O Antigens of their lipopolysaccharides.

33. Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin-acinetobacter-neurofilament antibody index.

34. Generation and serological characterization of murine monoclonal antibodies against O antigens from Acinetobacter reference strains.

35. O-antigen diversity among Acinetobacter baumannii strains from the Czech Republic and Northwestern Europe, as determined by lipopolysaccharide-specific monoclonal antibodies.

36. Monoclonal antibodies against the iron regulated outer membrane Proteins of Acinetobacter baumannii are bactericidal.

37. Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.

38. Effect of EDTA on the resistance of clinical isolates of Acinetobacter baumannii to the bactericidal activity of normal human serum.

39. Surveillance of nosocomial cross-infections due to three Acinetobacter genospecies (Acinetobacter baumannii, genospecies 3 and genospecies 13) during a 10-Year Observation period: serotyping, macrorestriction analysis of Genomic DNA and antibiotic susceptibilities.

40. Antibody response to lipopolysaccharide in patients colonized or infected with an endemic strain of Acinetobacter genomic species 13 sensu Tjernberg and Ursing.

41. Examination of polyclonal rabbit immune sera against serovars of Acinetobacter baumannii and genospecies 3 for cross-reactions with reference strains of other named/unnamed genospecies of Acinetobacter.

42. Chemical and antigenic structure of the O-polysaccharide of the lipopolysaccharides from two Acinetobacter haemolyticus strains differing only in the anomeric configuration of one glycosyl residue in their O-antigens.

43. Structure of the O-specific polysaccharide for Acinetobacter baumannii serogroup O1.

44. Effects of cytokines and endotoxin on the intracellular growth of bacteria.

45. Identification of Acinetobacter baumannii strains with monoclonal antibodies against the O antigens of their lipopolysaccharides.

46. Some immunological properties of lipopolysaccharide from Acinetobacter baumannii.

47. Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter.

48. Structural studies of the O-antigen isolated from the phenol-soluble lipopolysaccharide of Acinetobacter baumannii (DNA group 2) strain 9.

49. Structure of the O-7 antigen from Acinetobacter baumannii.

50. Structure of the O18 antigen from Acinetobacter baumannii.

Catalog

Books, media, physical & digital resources